LIPITOR
Drug
PFIZER INC.
Total Payments
$437,323
Transactions
67
Doctors
14
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $3,384 | 5 | 1 |
| 2019 | $27,815 | 11 | 4 |
| 2018 | $61,892 | 21 | 6 |
| 2017 | $344,232 | 30 | 9 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $314,086 | 8 | 71.8% |
| Consulting Fee | $93,780 | 20 | 21.4% |
| Travel and Lodging | $28,074 | 27 | 6.4% |
| Food and Beverage | $1,383 | 12 | 0.3% |
Payments by Type
Research
$314,086
8 transactions
General
$123,237
59 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ZHAOLIPITORSUPPORT THE SATELITE RESEARCH CLINIC ACTIVITIES IN BOISE ID FOR STUDY OF CARTOID PLAQUE COMP | PFIZER INC. | $302,648 | 0 |
| LIPITOR IN INFANTS AND CHILDREN WITH CORONARY ARTERY ABNORMALITIES IN ACUTE KAWASAKI DISEASE | PFIZER INC. | $11,439 | 0 |
Top Doctors Receiving Payments for LIPITOR
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Seattle, WA | $314,086 | 8 |
| , MD | Internal Medicine | San Francisco, CA | $59,623 | 17 |
| , MD | Cardiovascular Disease | Iowa City, IA | $16,960 | 7 |
| , MD | Specialist | Carlsbad, CA | $15,908 | 2 |
| , MD | Cardiovascular Disease | New York, NY | $11,840 | 2 |
| , M.D., M.H.A | Cardiovascular Disease | New York, NY | $8,342 | 4 |
| , MD | Internal Medicine | San Francisco, CA | $3,705 | 6 |
| , M.D | Cardiovascular Disease | Falls Church, VA | $3,384 | 5 |
| , M.D | Neurology | Mclean, VA | $1,184 | 4 |
| , M.D | Public Health & General Preventive Medicine | Reston, VA | $1,154 | 4 |
| , MD | Medical Toxicology | Denver, CO | $1,091 | 4 |
| , M.D | Family Medicine | Saint Louis, MO | $15.10 | 1 |
| , M.D | Cardiovascular Disease | Saint Louis, MO | $15.10 | 1 |
| , M.D | Internal Medicine | Pittsburgh, PA | $7.23 | 1 |
| , D.O | Family Medicine | Pittsburgh, PA | $7.23 | 1 |
Ad
Manufacturing Companies
- PFIZER INC. $433,939
- Mylan Inc. $3,384
Product Information
- Type Drug
- Total Payments $437,323
- Total Doctors 14
- Transactions 67
About LIPITOR
LIPITOR is a drug associated with $437,323 in payments to 14 healthcare providers, recorded across 67 transactions in the CMS Open Payments database. The primary manufacturer is PFIZER INC..
Payment data is available from 2017 to 2024. In 2024, $3,384 was paid across 5 transactions to 1 doctors.
The most common payment nature for LIPITOR is "Unspecified" ($314,086, 71.8% of total).
LIPITOR is associated with 2 research studies, including "ZHAOLIPITORSUPPORT THE SATELITE RESEARCH CLINIC ACTIVITIES IN BOISE ID FOR STUDY OF CARTOID PLAQUE COMP" ($302,648).